Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 337,248 shares at $20.29 ($6.8M) on 2026-04-17, disclosed to the SEC on 2026-04-21.
Scheduled sale ($6.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.29 | 211,974 | $4.3M | 63.1% |
| 2 | $20.07 | 125,274 | $2.5M | 36.9% |
| Total | $20.21 avg | 337,248 | $6.8M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-17 | $2.0M | — | Filing → |